Article Versions Notes

Corona A, Ballana E, Distinto S, Rogolino D, Del Vecchio C, Carcelli M, Badia R, Riveira-Muñoz E, Esposito F, Parolin C, et al. Targeting HIV-1 RNase H: N’-(2-Hydroxy-benzylidene)-3,4,5-Trihydroxybenzoylhydrazone as Selective Inhibitor Active against NNRTIs-Resistant Variants. Viruses. 2020; 12(7):729. https://doi.org/10.3390/v12070729

Corona, Angela, Ester Ballana, Simona Distinto, Dominga Rogolino, Claudia Del Vecchio, Mauro Carcelli, Roger Badia, Eva Riveira-Muñoz, Francesca Esposito, Cristina Parolin, and et al. 2020. "Targeting HIV-1 RNase H: N’-(2-Hydroxy-benzylidene)-3,4,5-Trihydroxybenzoylhydrazone as Selective Inhibitor Active against NNRTIs-Resistant Variants" Viruses 12, no. 7: 729. https://doi.org/10.3390/v12070729

Corona, A., Ballana, E., Distinto, S., Rogolino, D., Del Vecchio, C., Carcelli, M., Badia, R., Riveira-Muñoz, E., Esposito, F., Parolin, C., Esté, J. A., Grandi, N., & Tramontano, E. (2020). Targeting HIV-1 RNase H: N’-(2-Hydroxy-benzylidene)-3,4,5-Trihydroxybenzoylhydrazone as Selective Inhibitor Active against NNRTIs-Resistant Variants. Viruses, 12(7), 729. https://doi.org/10.3390/v12070729